Biggest News Aggregation in the World
📰 Gil Efron News

Page 2 - Gil Efron News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Gil Efron. Real-time updates on events, politics, business and more.

NT219 Plus Cetuximab Elicits Responses, Demonstrates Tolerability in Recurrent or Metastatic HNSCC

Second-line treatment with NT219 alone and in combination with cetuximab demonstrated safety and tolerability, and the combination produced confirmed partial responses in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
United States University Of Chicago Gil Efron Purple Biotech Accessed October Head And Neck Squamous Cell Carcinoma

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science